Amgen Inc
Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%
Amgen Non-GAAP Research & Development Expense by Year
Non-GAAP Research & Development Expense ($M) ($M)
Amgen Non-GAAP Research & Development Expense: $7,183M in FY2025, up 22.2% from a year earlier. That is the highest of the 9 years on record here.
Where the FY2025 figure comes from
“|| Non-GAAP research and development expenses | $ | 2,133 | $ | 1,698 | $ | 7,183 | $ | 5,878”
Source: Form 8-K (amgn-20251231earningsrelea.htm, filed 2026-02-03) ↗
Reported in Form 8-K Reconciliations of GAAP to Non-GAAP Measures.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP Research & Development Expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7,183 | +22.2% | Form 8-K (amgn-20251231earningsrelea.htm, filed 2026-02-03) ↗ |
| FY2024 | Dec 31, 2024 | 5,878 | +25.1% | Form 8-K (amgn-20241231earningsrelea.htm, filed 2025-02-04) ↗ |
| FY2023 | Dec 31, 2023 | 4,700 | +8.3% | Form 8-K (amgn-20231231earningsrelea.htm, filed 2024-02-06) ↗ |
| FY2022 | Dec 31, 2022 | 4,341 | +1.0% | Form 8-K (amgn-20221231earningsrelea.htm, filed 2023-01-31) ↗ |
| FY2021 | Dec 31, 2021 | 4,296 | +5.2% | Form 8-K (amgenq42021earningsrelease.htm, filed 2022-02-07) ↗ |
| FY2020 | Dec 31, 2020 | 4,085 | +1.4% | Form 8-K (amgn-20201231xq4ex991.htm, filed 2021-02-02) ↗ |
| FY2019 | Dec 31, 2019 | 4,027 | +10.1% | Form 8-K (amgn-20191231xq4ex991.htm, filed 2020-01-30) ↗ |
| FY2018 | Dec 31, 2018 | 3,657 | +5.0% | Form 8-K (amgn-20181231xq4exhibit991.htm, filed 2019-01-29) ↗ |
| FY2017 | Dec 31, 2017 | 3,482 | – | Form 8-K (amgn-20181231xq4exhibit991.htm, filed 2019-01-29) ↗ |
Breakdown
What makes up non-GAAP Research & Development Expense
Cite this data
StockData. (2026). Amgen Non-GAAP Research & Development Expense ($M), annual FY2017–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/ng-rd
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.